Reporter March 13 2020

COVID-19 information

Vanderbilt University Medical Center’s response to the ongoing coronavirus (COVID-19) situation is wide-ranging, comprehensive and ever evolving.

Diagnostic testing for genetic disorders now available on site

Vanderbilt University Medical Center has opened a Clinical Genomics Laboratory to provide diagnostic testing for genetic disorders.

VUMC’s ECMO program has expanded to areas outside of the Cardiovascular Intensive Care Unit.

ECMO team to help other providers create their own programs

VUMC has signed an agreement with Ballad Health, a regional health system serving East Tennessee and Southwest Virginia, to train its team to provide a life-saving medical program called ECMO.

Installing the wireless pacemaker requires only a minimally invasive surgery using a catheter inserted in a vein.

Tiny pacemaker helps keep patient’s heart in rhythm

In February, Martha Hawks became the Southeast’s first recipient of the Medtronic Micra AV, the latest version of the tiny pacemaker that Vanderbilt Heart and Vascular Institute began testing in a clinical trial in 2014. The FDA approved the latest device in January.

Triple-negative breast cancer drug therapy shows promise

Researchers from Vanderbilt-Ingram Cancer Center (VICC) discovered a role for MYCN in triple-negative breast cancer (TNBC), a particularly aggressive form of the disease, and identified a potential intervention for further clinical investigation.

Study explores health impact of social isolation, loneliness

For older adults, social isolation and loneliness are associated with greatly increased likelihood of early death, dementia and heart disease, according to a recent report by the National Academy of Medicine (NAM).

1 2